Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.640
-0.030 (-1.80%)
Nov 22, 2024, 4:00 PM EST - Market closed
Accelerate Diagnostics Employees
Accelerate Diagnostics had 134 employees as of December 31, 2023. The number of employees decreased by 45 or -25.14% compared to the previous year.
Employees
134
Change (1Y)
-45
Growth (1Y)
-25.14%
Revenue / Employee
$88,873
Profits / Employee
-$398,910
Market Cap
41.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
Barinthus Biotherapeutics | 130 |
Xilio Therapeutics | 73 |
LAVA Therapeutics | 37 |
Iterum Therapeutics | 14 |
Lexaria Bioscience | 5 |
OS Therapies | 4 |
Anebulo Pharmaceuticals | 3 |
AXDX News
- 14 days ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 7 weeks ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 3 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Accelerate Diagnostics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial - PRNewsWire
- 3 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results - PRNewsWire